| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Meniere Disease | 9 | 2022 | 31 | 2.620 |
Why?
|
| Ear Diseases | 5 | 2022 | 37 | 2.300 |
Why?
|
| Tinnitus | 3 | 2021 | 22 | 2.220 |
Why?
|
| Otitis Media | 5 | 2022 | 35 | 2.210 |
Why?
|
| Otitis Externa | 5 | 2020 | 14 | 2.050 |
Why?
|
| Ossicular Replacement | 4 | 2017 | 7 | 1.970 |
Why?
|
| Cochlear Implants | 11 | 2021 | 110 | 1.840 |
Why?
|
| Cochlear Implantation | 6 | 2021 | 99 | 1.660 |
Why?
|
| Eustachian Tube | 2 | 2022 | 31 | 1.560 |
Why?
|
| Tympanoplasty | 6 | 2022 | 13 | 1.520 |
Why?
|
| Ossicular Prosthesis | 3 | 2017 | 10 | 1.420 |
Why?
|
| Hearing Loss, Noise-Induced | 2 | 2021 | 46 | 1.410 |
Why?
|
| Neuroma, Acoustic | 5 | 2019 | 17 | 1.350 |
Why?
|
| Cholesteatoma, Middle Ear | 4 | 2022 | 9 | 1.330 |
Why?
|
| Ear, Middle | 7 | 2021 | 32 | 1.280 |
Why?
|
| Ear Canal | 7 | 2016 | 24 | 1.170 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 5 | 2016 | 15 | 1.110 |
Why?
|
| Hearing Loss, Sensorineural | 5 | 2022 | 110 | 1.070 |
Why?
|
| Hearing Loss | 3 | 2022 | 154 | 1.020 |
Why?
|
| Glucocorticoids | 3 | 2020 | 222 | 1.020 |
Why?
|
| Ear, Inner | 3 | 2022 | 47 | 0.960 |
Why?
|
| Ear Neoplasms | 3 | 2015 | 13 | 0.960 |
Why?
|
| Tympanic Membrane | 5 | 2019 | 25 | 0.940 |
Why?
|
| Temporal Bone | 11 | 2018 | 53 | 0.940 |
Why?
|
| Dexamethasone | 2 | 2016 | 150 | 0.930 |
Why?
|
| Humans | 83 | 2022 | 68618 | 0.920 |
Why?
|
| Otologic Surgical Procedures | 6 | 2021 | 23 | 0.920 |
Why?
|
| Vertigo | 5 | 2016 | 24 | 0.900 |
Why?
|
| Hearing | 6 | 2022 | 133 | 0.880 |
Why?
|
| Bone Conduction | 5 | 2016 | 9 | 0.870 |
Why?
|
| Cholesteatoma | 1 | 2022 | 4 | 0.850 |
Why?
|
| Treatment Outcome | 20 | 2022 | 7029 | 0.840 |
Why?
|
| Deafness | 5 | 2020 | 64 | 0.820 |
Why?
|
| Psoriasis | 1 | 2022 | 46 | 0.810 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2021 | 33 | 0.780 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2020 | 11 | 0.740 |
Why?
|
| Reoperation | 5 | 2017 | 467 | 0.740 |
Why?
|
| Hearing Loss, Unilateral | 1 | 2020 | 7 | 0.730 |
Why?
|
| Adult | 42 | 2021 | 21403 | 0.710 |
Why?
|
| Adrenal Cortex Hormones | 3 | 2020 | 186 | 0.710 |
Why?
|
| Transcutaneous Electric Nerve Stimulation | 1 | 2020 | 40 | 0.700 |
Why?
|
| Auditory Threshold | 7 | 2016 | 206 | 0.690 |
Why?
|
| Middle Aged | 40 | 2021 | 21147 | 0.670 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2021 | 142 | 0.670 |
Why?
|
| Titanium | 4 | 2017 | 118 | 0.660 |
Why?
|
| Aged | 31 | 2021 | 14862 | 0.640 |
Why?
|
| Mastoid | 6 | 2022 | 20 | 0.630 |
Why?
|
| Retrospective Studies | 25 | 2022 | 7277 | 0.610 |
Why?
|
| Stapes | 3 | 2015 | 7 | 0.590 |
Why?
|
| Neurotology | 2 | 2018 | 7 | 0.590 |
Why?
|
| Hearing Tests | 3 | 2018 | 70 | 0.580 |
Why?
|
| Skull Base | 5 | 2018 | 72 | 0.570 |
Why?
|
| Otitis Media, Suppurative | 1 | 2016 | 4 | 0.560 |
Why?
|
| Intracranial Hypertension | 1 | 2017 | 53 | 0.550 |
Why?
|
| Female | 49 | 2019 | 38074 | 0.530 |
Why?
|
| Male | 49 | 2019 | 37321 | 0.530 |
Why?
|
| Skull Neoplasms | 4 | 2012 | 23 | 0.500 |
Why?
|
| Adolescent | 22 | 2021 | 8912 | 0.490 |
Why?
|
| Prosthesis Implantation | 1 | 2015 | 83 | 0.490 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2015 | 36 | 0.490 |
Why?
|
| Lymphoma, B-Cell | 1 | 2015 | 40 | 0.480 |
Why?
|
| Carotid Artery, Internal | 2 | 2014 | 85 | 0.480 |
Why?
|
| Aneurysm, False | 1 | 2014 | 60 | 0.460 |
Why?
|
| Hearing Loss, Conductive | 5 | 2005 | 12 | 0.440 |
Why?
|
| Child, Preschool | 13 | 2019 | 3187 | 0.440 |
Why?
|
| Vestibule, Labyrinth | 2 | 2010 | 19 | 0.440 |
Why?
|
| Postoperative Complications | 7 | 2018 | 1615 | 0.430 |
Why?
|
| Audiometry | 7 | 2019 | 50 | 0.420 |
Why?
|
| Embolization, Therapeutic | 1 | 2014 | 150 | 0.410 |
Why?
|
| Papilloma, Inverted | 1 | 2012 | 8 | 0.410 |
Why?
|
| Tomography, X-Ray Computed | 14 | 2018 | 2324 | 0.400 |
Why?
|
| Prospective Studies | 6 | 2021 | 3705 | 0.400 |
Why?
|
| Child | 20 | 2019 | 6405 | 0.390 |
Why?
|
| Chronic Disease | 5 | 2022 | 1330 | 0.390 |
Why?
|
| Audiometry, Pure-Tone | 4 | 2022 | 96 | 0.380 |
Why?
|
| Semicircular Canals | 2 | 2016 | 9 | 0.380 |
Why?
|
| Young Adult | 9 | 2021 | 5717 | 0.370 |
Why?
|
| Facial Nerve | 5 | 2017 | 25 | 0.370 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 235 | 0.360 |
Why?
|
| Aged, 80 and over | 14 | 2021 | 4848 | 0.360 |
Why?
|
| Craniotomy | 1 | 2010 | 33 | 0.350 |
Why?
|
| Cerebrospinal Fluid Rhinorrhea | 1 | 2010 | 41 | 0.350 |
Why?
|
| Cerebrospinal Fluid Leak | 3 | 2018 | 32 | 0.330 |
Why?
|
| Facial Nerve Diseases | 2 | 2015 | 13 | 0.320 |
Why?
|
| Diagnosis, Differential | 4 | 2017 | 1140 | 0.320 |
Why?
|
| Head and Neck Neoplasms | 3 | 2018 | 561 | 0.290 |
Why?
|
| Cochlea | 3 | 2017 | 169 | 0.280 |
Why?
|
| Obesity | 4 | 2018 | 1076 | 0.270 |
Why?
|
| Skin Transplantation | 2 | 2016 | 45 | 0.260 |
Why?
|
| Hair Cells, Auditory | 2 | 1997 | 60 | 0.260 |
Why?
|
| Postoperative Period | 3 | 2021 | 238 | 0.250 |
Why?
|
| Otosclerosis | 1 | 2004 | 2 | 0.250 |
Why?
|
| Stapes Surgery | 1 | 2004 | 3 | 0.250 |
Why?
|
| Encephalocele | 2 | 2017 | 30 | 0.230 |
Why?
|
| Posture | 1 | 2004 | 107 | 0.230 |
Why?
|
| Pseudotumor Cerebri | 2 | 2017 | 43 | 0.230 |
Why?
|
| Facial Nerve Injuries | 2 | 1998 | 4 | 0.220 |
Why?
|
| Severity of Illness Index | 6 | 2018 | 1851 | 0.210 |
Why?
|
| Mastoidectomy | 1 | 2022 | 7 | 0.210 |
Why?
|
| Otorhinolaryngologic Diseases | 1 | 2002 | 14 | 0.210 |
Why?
|
| Follow-Up Studies | 6 | 2016 | 3259 | 0.210 |
Why?
|
| Endolymphatic Hydrops | 1 | 2022 | 4 | 0.210 |
Why?
|
| Acoustic Impedance Tests | 1 | 2021 | 11 | 0.200 |
Why?
|
| Dilatation | 1 | 2022 | 58 | 0.200 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2002 | 62 | 0.200 |
Why?
|
| Double-Blind Method | 3 | 2016 | 1738 | 0.200 |
Why?
|
| Evoked Potentials, Auditory | 4 | 1990 | 47 | 0.200 |
Why?
|
| Quality of Life | 2 | 2021 | 1515 | 0.190 |
Why?
|
| Pressure | 1 | 2021 | 252 | 0.190 |
Why?
|
| Cartilage | 1 | 2000 | 51 | 0.180 |
Why?
|
| Ciprofloxacin | 1 | 2020 | 30 | 0.180 |
Why?
|
| Saccule and Utricle | 2 | 1997 | 7 | 0.180 |
Why?
|
| Speech Reception Threshold Test | 2 | 2016 | 25 | 0.180 |
Why?
|
| Ear, External | 2 | 1998 | 14 | 0.180 |
Why?
|
| Recurrence | 3 | 2016 | 948 | 0.170 |
Why?
|
| Noise | 1 | 2021 | 153 | 0.170 |
Why?
|
| Pain Measurement | 1 | 2020 | 328 | 0.170 |
Why?
|
| Hearing Disorders | 2 | 2017 | 23 | 0.160 |
Why?
|
| Facial Paralysis | 4 | 2005 | 25 | 0.160 |
Why?
|
| SEER Program | 1 | 2019 | 153 | 0.160 |
Why?
|
| Prevalence | 2 | 2020 | 1619 | 0.160 |
Why?
|
| Hospitals, Low-Volume | 1 | 2018 | 12 | 0.160 |
Why?
|
| Hospitals, High-Volume | 1 | 2018 | 18 | 0.160 |
Why?
|
| Dizziness | 1 | 1997 | 27 | 0.150 |
Why?
|
| Bone Density | 1 | 2018 | 159 | 0.150 |
Why?
|
| Guinea Pigs | 1 | 1997 | 124 | 0.150 |
Why?
|
| Otolaryngology | 1 | 2018 | 38 | 0.150 |
Why?
|
| Intraoperative Complications | 1 | 1998 | 129 | 0.150 |
Why?
|
| Quality Improvement | 1 | 2021 | 413 | 0.150 |
Why?
|
| Injection, Intratympanic | 1 | 2016 | 1 | 0.140 |
Why?
|
| Audiometry, Evoked Response | 4 | 2006 | 8 | 0.140 |
Why?
|
| Universities | 1 | 2018 | 191 | 0.140 |
Why?
|
| Physical Examination | 1 | 1997 | 152 | 0.140 |
Why?
|
| Risk Assessment | 2 | 2018 | 2007 | 0.140 |
Why?
|
| Publishing | 1 | 2018 | 89 | 0.140 |
Why?
|
| Delayed-Action Preparations | 1 | 2016 | 120 | 0.140 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2017 | 114 | 0.140 |
Why?
|
| Aspergillosis | 1 | 2015 | 20 | 0.130 |
Why?
|
| Escherichia coli Infections | 1 | 2015 | 47 | 0.130 |
Why?
|
| Prosthesis Design | 3 | 2008 | 301 | 0.130 |
Why?
|
| Osteomyelitis | 1 | 2015 | 40 | 0.130 |
Why?
|
| Facial Muscles | 1 | 2015 | 11 | 0.120 |
Why?
|
| Vestibulocochlear Nerve Diseases | 2 | 1992 | 10 | 0.120 |
Why?
|
| Registries | 1 | 2018 | 733 | 0.120 |
Why?
|
| Pseudomonas Infections | 1 | 2015 | 83 | 0.120 |
Why?
|
| Endolymphatic Sac | 1 | 2014 | 6 | 0.120 |
Why?
|
| Transforming Growth Factor alpha | 1 | 1994 | 30 | 0.120 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 2 | 1992 | 49 | 0.120 |
Why?
|
| Surveys and Questionnaires | 2 | 2022 | 2800 | 0.120 |
Why?
|
| Decompression, Surgical | 1 | 2014 | 55 | 0.120 |
Why?
|
| Staphylococcal Infections | 1 | 2015 | 156 | 0.120 |
Why?
|
| Diabetes Complications | 1 | 2015 | 249 | 0.110 |
Why?
|
| Angiography | 1 | 2014 | 194 | 0.110 |
Why?
|
| Regeneration | 1 | 1994 | 105 | 0.110 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 1465 | 0.110 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 1992 | 20 | 0.110 |
Why?
|
| Vestibulocochlear Nerve | 1 | 1992 | 17 | 0.100 |
Why?
|
| Carcinoma | 2 | 2007 | 215 | 0.100 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 1992 | 13 | 0.100 |
Why?
|
| South Carolina | 2 | 2017 | 2752 | 0.100 |
Why?
|
| Placebos | 1 | 2012 | 195 | 0.100 |
Why?
|
| Speech Perception | 3 | 2017 | 261 | 0.100 |
Why?
|
| Parotid Neoplasms | 1 | 1991 | 49 | 0.100 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 567 | 0.100 |
Why?
|
| Cochlear Diseases | 1 | 1991 | 2 | 0.090 |
Why?
|
| Labyrinthitis | 1 | 1991 | 2 | 0.090 |
Why?
|
| Cranial Fossa, Middle | 1 | 2010 | 8 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 369 | 0.090 |
Why?
|
| Empty Sella Syndrome | 1 | 2010 | 10 | 0.090 |
Why?
|
| Meningocele | 1 | 2010 | 12 | 0.090 |
Why?
|
| Ossification, Heterotopic | 1 | 1991 | 45 | 0.090 |
Why?
|
| Mucocele | 1 | 2010 | 20 | 0.090 |
Why?
|
| Keratosis | 2 | 2007 | 17 | 0.090 |
Why?
|
| Risk Factors | 2 | 2018 | 5731 | 0.090 |
Why?
|
| Abdominal Fat | 1 | 2010 | 8 | 0.090 |
Why?
|
| Mouth Diseases | 1 | 2010 | 39 | 0.090 |
Why?
|
| Oval Window, Ear | 1 | 1990 | 1 | 0.090 |
Why?
|
| Suture Techniques | 1 | 2010 | 75 | 0.090 |
Why?
|
| Transplantation, Autologous | 1 | 2010 | 145 | 0.090 |
Why?
|
| Ear | 1 | 1988 | 12 | 0.080 |
Why?
|
| Algorithms | 1 | 2014 | 1196 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 1745 | 0.080 |
Why?
|
| Patient Satisfaction | 3 | 2021 | 378 | 0.080 |
Why?
|
| Electric Stimulation | 4 | 1997 | 218 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 2223 | 0.080 |
Why?
|
| Leukoplakia, Oral | 1 | 2007 | 12 | 0.070 |
Why?
|
| Gingival Neoplasms | 1 | 2007 | 13 | 0.070 |
Why?
|
| Alveolar Process | 1 | 2007 | 18 | 0.070 |
Why?
|
| Dermatitis, Seborrheic | 1 | 1987 | 3 | 0.070 |
Why?
|
| Mitomycin | 1 | 2006 | 27 | 0.070 |
Why?
|
| Otitis Media with Effusion | 1 | 1986 | 9 | 0.070 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2006 | 82 | 0.070 |
Why?
|
| Osteopetrosis | 1 | 2005 | 8 | 0.060 |
Why?
|
| Loudness Perception | 2 | 1997 | 13 | 0.060 |
Why?
|
| Time Factors | 3 | 2008 | 4655 | 0.060 |
Why?
|
| Fibrous Dysplasia of Bone | 1 | 1984 | 6 | 0.060 |
Why?
|
| Microscopy, Electron | 2 | 1997 | 351 | 0.060 |
Why?
|
| Carotid Artery Diseases | 1 | 1985 | 83 | 0.060 |
Why?
|
| Skull Fractures | 1 | 1984 | 17 | 0.060 |
Why?
|
| Glomus Jugulare Tumor | 1 | 1984 | 4 | 0.060 |
Why?
|
| Paraganglioma, Extra-Adrenal | 1 | 1984 | 3 | 0.060 |
Why?
|
| Paraganglioma | 1 | 1984 | 8 | 0.060 |
Why?
|
| Geriatric Assessment | 1 | 2004 | 107 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1553 | 0.060 |
Why?
|
| Infant | 3 | 2010 | 2891 | 0.050 |
Why?
|
| Recovery of Function | 1 | 2004 | 506 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2004 | 931 | 0.040 |
Why?
|
| Incus | 2 | 1990 | 3 | 0.040 |
Why?
|
| Prognosis | 1 | 2004 | 2093 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2021 | 214 | 0.040 |
Why?
|
| Radiography | 2 | 2014 | 572 | 0.040 |
Why?
|
| Collagen | 1 | 2002 | 636 | 0.040 |
Why?
|
| Sural Nerve | 1 | 1998 | 4 | 0.040 |
Why?
|
| Morbidity | 1 | 2018 | 130 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 1998 | 236 | 0.040 |
Why?
|
| Reflex, Acoustic | 1 | 1997 | 7 | 0.040 |
Why?
|
| Epithelium | 2 | 2002 | 172 | 0.040 |
Why?
|
| Neurologic Examination | 1 | 1997 | 107 | 0.040 |
Why?
|
| United States | 3 | 2018 | 7367 | 0.030 |
Why?
|
| Focus Groups | 1 | 2017 | 247 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2018 | 384 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 1998 | 951 | 0.030 |
Why?
|
| Debridement | 1 | 2015 | 55 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 1056 | 0.030 |
Why?
|
| Age Factors | 2 | 2010 | 1864 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 2077 | 0.030 |
Why?
|
| Length of Stay | 1 | 2018 | 780 | 0.030 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2015 | 92 | 0.030 |
Why?
|
| Hair Cells, Vestibular | 1 | 1994 | 6 | 0.030 |
Why?
|
| Birds | 1 | 1994 | 17 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 1994 | 44 | 0.030 |
Why?
|
| Growth Substances | 1 | 1994 | 77 | 0.030 |
Why?
|
| Organ Culture Techniques | 1 | 1994 | 122 | 0.030 |
Why?
|
| Mitosis | 1 | 1994 | 76 | 0.030 |
Why?
|
| Cell Count | 1 | 1994 | 248 | 0.030 |
Why?
|
| Regression Analysis | 1 | 1995 | 737 | 0.030 |
Why?
|
| Hernia | 1 | 1992 | 13 | 0.030 |
Why?
|
| Animals | 3 | 2006 | 20881 | 0.030 |
Why?
|
| Disease Progression | 1 | 2015 | 1038 | 0.020 |
Why?
|
| Up-Regulation | 1 | 1994 | 682 | 0.020 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1992 | 47 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2014 | 867 | 0.020 |
Why?
|
| Hyalin | 1 | 2010 | 8 | 0.020 |
Why?
|
| Cheek | 1 | 2010 | 11 | 0.020 |
Why?
|
| Lip Diseases | 1 | 2010 | 8 | 0.020 |
Why?
|
| Mouth Floor | 1 | 2010 | 9 | 0.020 |
Why?
|
| Palate | 1 | 2010 | 14 | 0.020 |
Why?
|
| Metaplasia | 1 | 2010 | 27 | 0.020 |
Why?
|
| Tongue Diseases | 1 | 2010 | 14 | 0.020 |
Why?
|
| Color | 1 | 2010 | 50 | 0.020 |
Why?
|
| Rupture | 1 | 2010 | 29 | 0.020 |
Why?
|
| Mouth Mucosa | 1 | 2010 | 51 | 0.020 |
Why?
|
| Mouth | 1 | 2010 | 64 | 0.020 |
Why?
|
| Surgical Procedures, Operative | 1 | 1991 | 124 | 0.020 |
Why?
|
| Hospitalization | 1 | 2015 | 978 | 0.020 |
Why?
|
| Reaction Time | 1 | 1990 | 170 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2015 | 694 | 0.020 |
Why?
|
| Malleus | 1 | 1988 | 2 | 0.020 |
Why?
|
| Electrodes, Implanted | 1 | 1989 | 98 | 0.020 |
Why?
|
| Reference Values | 1 | 1990 | 579 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 1026 | 0.020 |
Why?
|
| Meningitis | 1 | 1987 | 23 | 0.020 |
Why?
|
| Jaw, Edentulous, Partially | 1 | 2007 | 3 | 0.020 |
Why?
|
| Warts | 1 | 2007 | 6 | 0.020 |
Why?
|
| Gingival Diseases | 1 | 2007 | 22 | 0.020 |
Why?
|
| Erythema | 1 | 2007 | 18 | 0.020 |
Why?
|
| Oral Ulcer | 1 | 2007 | 22 | 0.020 |
Why?
|
| Amoxicillin | 1 | 1986 | 10 | 0.020 |
Why?
|
| Audiometry, Speech | 1 | 1986 | 14 | 0.020 |
Why?
|
| Precancerous Conditions | 1 | 2007 | 74 | 0.020 |
Why?
|
| Administration, Topical | 1 | 2006 | 111 | 0.020 |
Why?
|
| Sex Factors | 1 | 2010 | 1266 | 0.020 |
Why?
|
| Gerbillinae | 1 | 2006 | 156 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2006 | 127 | 0.020 |
Why?
|
| Prednisone | 1 | 1986 | 104 | 0.020 |
Why?
|
| Electronystagmography | 1 | 1985 | 2 | 0.020 |
Why?
|
| Action Potentials | 1 | 2006 | 223 | 0.020 |
Why?
|
| Administration, Oral | 1 | 1986 | 411 | 0.020 |
Why?
|
| Methods | 1 | 1985 | 156 | 0.020 |
Why?
|
| Random Allocation | 1 | 1986 | 442 | 0.020 |
Why?
|
| Biopsy | 1 | 2007 | 540 | 0.020 |
Why?
|
| Geniculate Ganglion | 1 | 1984 | 3 | 0.020 |
Why?
|
| Electrodiagnosis | 1 | 1984 | 12 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 1986 | 649 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 1986 | 848 | 0.010 |
Why?
|
| Mice | 1 | 1994 | 8474 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2005 | 1054 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2007 | 629 | 0.010 |
Why?
|
| Incidence | 1 | 2005 | 1603 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2007 | 805 | 0.010 |
Why?
|
| Smoking | 1 | 2007 | 1452 | 0.010 |
Why?
|
| Psychophysics | 1 | 1997 | 30 | 0.010 |
Why?
|
| Sensory Thresholds | 1 | 1997 | 50 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 219 | 0.010 |
Why?
|
| Pain Threshold | 1 | 1997 | 55 | 0.010 |
Why?
|
| Monitoring, Physiologic | 2 | 1988 | 219 | 0.010 |
Why?
|
| Hearing Aids | 1 | 1997 | 34 | 0.010 |
Why?
|
| Acoustic Stimulation | 1 | 1997 | 206 | 0.010 |
Why?
|
| Forecasting | 1 | 1997 | 277 | 0.010 |
Why?
|
| Labyrinth Diseases | 1 | 1988 | 3 | 0.010 |
Why?
|
| Data Collection | 1 | 1990 | 420 | 0.000 |
Why?
|
| Intraoperative Period | 1 | 1988 | 62 | 0.000 |
Why?
|